Navigation Links
Important breakthrough in identifying effect of epilepsy treatment
Date:10/31/2013

50 years after valproate was first discovered, research published today in the journal Neurobiology of Disease, reports how the drug works to block seizure progression.

Valproate (variously labelled worldwide as Epilim, Depacon, Depakene, Depakote, Orlept, Episenta, Orfiril, and Convulex) is one of the world's most highly prescribed treatments for epilepsy. It was first discovered to be an effective treatment for epilepsy, by accident, in 1963 by a group of French scientists.

In thousands of subsequent experiments, animals have been used to investigate how valproate blocks seizures, without success. Scientists from Royal Holloway University and University College London have now identified how valproate blocks seizures in the brain, by using a simple amoeba.

"The discovery of how valproate blocks seizures, initially using the social amoeba Dictyostelium, and then replicated using accepted seizure models, highlights the successful use of non-animal testing in biomedical research," said Professor Robin Williams from the School of Biological Sciences at Royal Holloway.

"Sodium valproate is one of the most effective antiepileptic drugs in many people with epilepsy, but its use has been limited by side-effects, in particular its effect in pregnant women on the unborn child," said Professor Matthew Walker from the Institute of Neurology at University College London. "Understanding valproate's mechanism of action is a first step to developing even more effective drugs that lack many of valproate's side-effects."

"Our study also found that the decrease of a specific chemical in the brain at the start of the seizure causes even more seizure activity. This holds important implications for identifying underlying causes," added Professor Williams.


'/>"/>

Contact: Tanya Gubbay
tanya.gubbay@rhul.ac.uk
Royal Holloway, University of London
Source:Eurekalert

Page: 1

Related biology technology :

1. New method for producing precursor of neurons, bone and other important tissues from stem cells
2. Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
3. Carbon nanotubes can double growth of cell cultures important in industry
4. Building Wireless Solution More Important than Ever with New Tablets
5. Man-made pores mimic important features of natural pores
6. Appeal Courts Direction on Claim Construction Is Strategically Important for Butamaxs Case Against Gevo Scheduled for April 2013
7. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
8. Max Planck Florida Institute Important to Jupiter, Waterfront Properties Says
9. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
10. How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today
11. Microfabrication breakthrough could set piezoelectric material applications in motion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2019)... ... 2019 , ... Cheyenne is a beautiful and strong Quarter Horse and a ... Rebel’s Run , which offers riding lessons and trail riding in Afton, Virginia. ... Mimi describes her as her “go to horse.” Thus, you can imagine ...
(Date:10/3/2019)... (PRWEB) , ... October 03, 2019 , ... Yesterday, at ... Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important design ... To an attendee audience including both developers and suppliers of clinical trials, in his ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... company, has completed training and site qualification for clinical trial sites and physician ... and screening of potential clinical trial participants. , Clinical trial sites are currently ...
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was ... months old, Tucker was limping and lame on his right hip and elbow. At ... it was called “the worst case the vet had seen.” He was prescribed pain ...
Breaking Biology Technology:
(Date:10/3/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... stem cell treatment of knee osteoarthritis . The successful enrollment comes only a little ... Biopharma. , PSC CEO, Michael Dale, stated, “We are proud that as we celebrate ...
(Date:9/30/2019)... ALTO, Calif. (PRWEB) , ... September 30, 2019 ... ... public interest organization focused on molecular manufacturing and other transformative technologies, announced the ... categories, one for Experiment and the other for Theory in nanotechnology/molecular manufacturing. , ...
(Date:9/30/2019)... ... September 30, 2019 , ... As human induced pluripotent stem cells (hiPSCs) ... the development and diseases of the human heart, there is an increasing need for ... muscle cells to be clearly and easily recorded. A study released today in STEM ...
Breaking Biology News(10 mins):